X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anemia (2) 2
anemia - drug therapy (2) 2
anemia - etiology (2) 2
cause of death (2) 2
darbepoetin alfa (2) 2
endothelial progenitor cells (2) 2
epoetin alfa (2) 2
erythropoiesis stimulating protein (2) 2
erythropoietin - adverse effects (2) 2
erythropoietin - analogs & derivatives (2) 2
erythropoietin - pharmacokinetics (2) 2
erythropoietin - therapeutic use (2) 2
hematinics - therapeutic use (2) 2
humans (2) 2
index medicus (2) 2
kidney failure, chronic - complications (2) 2
kidney failure, chronic - mortality (2) 2
kidney failure, chronic - therapy (2) 2
mortality (2) 2
nephrology (2) 2
recombinant proteins - therapeutic use (2) 2
renal dialysis (2) 2
renal insufficiency, chronic - complications (2) 2
renal insufficiency, chronic - mortality (2) 2
trial (2) 2
urology & nephrology (2) 2
aged (1) 1
ambulatory care facilities (1) 1
article (1) 1
carbohydrate side chain (1) 1
cardiovascular (1) 1
cardiovascular diseases - mortality (1) 1
chronic kidney disease (1) 1
comorbidity (1) 1
dialysis patients (1) 1
diseases (1) 1
double-blind method (1) 1
drug safety (1) 1
end-stage renal disease (1) 1
erythropoiesis-stimulating agent (1) 1
erythropoiesis-stimulating agents (1) 1
female (1) 1
half-life (1) 1
hemodialysis (1) 1
hemodialysis units, hospital (1) 1
hemoglobin variability (1) 1
maintenance (1) 1
male (1) 1
meta-analysis (1) 1
middle aged (1) 1
myocardial infarction (1) 1
myocardial infarction - epidemiology (1) 1
peginesatide (1) 1
pharmacokinetics (1) 1
proportional hazards models (1) 1
randomized controlled trials as topic - statistics & numerical data (1) 1
recombinant erythropoietin (1) 1
recombinant human erythropoietin (1) 1
recombinant-human-erythropoietin (1) 1
registries (1) 1
renal anemia (1) 1
renal replacement therapy (1) 1
retrospective studies (1) 1
safety (1) 1
stroke (1) 1
stroke - epidemiology (1) 1
target hemoglobin (1) 1
treat (1) 1
treatment outcome (1) 1
united states - epidemiology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2015, Volume 66, Issue 1, pp. 106 - 113
Background Adequately powered studies directly comparing hard clinical outcomes of darbepoetin alfa (DPO) versus epoetin alfa (EPO) in patients undergoing... 
Nephrology | erythropoiesis-stimulating agent (ESA) | darbepoetin alfa (DPO) | epoetin alfa (EPO) | Mortality | safety | myocardial infarction | hemodialysis | renal replacement therapy (RRT) | cardiovascular | stroke | recombinant erythropoietin | PEGINESATIDE | TRIAL | ENDOTHELIAL PROGENITOR CELLS | DISEASES | DIALYSIS PATIENTS | UROLOGY & NEPHROLOGY | ERYTHROPOIESIS STIMULATING PROTEIN | ANEMIA | TREAT | Kidney Failure, Chronic - mortality | Recombinant Proteins - therapeutic use | United States - epidemiology | Myocardial Infarction - epidemiology | Erythropoietin - therapeutic use | Humans | Middle Aged | Erythropoietin - adverse effects | Male | Renal Insufficiency, Chronic - complications | Cause of Death | Erythropoietin - analogs & derivatives | Anemia - drug therapy | Cardiovascular Diseases - mortality | Renal Insufficiency, Chronic - mortality | Female | Registries | Stroke - epidemiology | Retrospective Studies | Epoetin Alfa | Anemia - etiology | Hematinics - therapeutic use | Comorbidity | Proportional Hazards Models | Treatment Outcome | Erythropoietin - pharmacokinetics | Hemodialysis Units, Hospital | Kidney Failure, Chronic - therapy | Kidney Failure, Chronic - complications | Ambulatory Care Facilities | Aged | Darbepoetin alfa | Renal Dialysis | Myocardial Infarction | Stroke | Cardiovascular | Safety
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.